ATIGEN-CELL   Report issue

For profit Phase 2
Founded: Ankara Turkey (2006)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2015
NCT02323477
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now